DMAC vs INVH · $157.4M cap vs P/E 42, rev $2.62B
DiaMedica Therapeutics Inc (DMAC) versus Invitation Homes Inc (INVH) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Invitation Homes Inc (INVH) is a reit - residential company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported INVH revenue for 2024-12-31 was $2.62B. Net income was $455.4M. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. INVH currently screens at market cap $19.99B and trailing P/E 41.8.
DMAC currently screens at market cap $157.4M. INVH currently screens at market cap $19.99B and trailing P/E 41.8.
Not investment advice. Open the DMAC and INVH stock pages for the full models.
Not investment advice.